Logo-aim
Arch Iran Med. 2013;16(5): 0.
PMID: 23641748
Scopus ID: 84877837785
  Abstract View: 2994
  PDF Download: 1436

Case Report

Cryptogenic Myocardial Infarction in Young Patients: Which is the Optimal Diagnostic and Therapeutic Management?

Cristina Giglioli, Serena Fatucchi, Miroslava Stolcova, Roberto Mercuri, Rosanna Abbate, Giorgio Galanti, Emanuele Cecchi*
*Corresponding Author: Email: emanuelececchi@virgilio.it

Abstract

A 31-year-old athlete was admitted to our hospital for previous inferior myocardial infarction (MI), diagnosed by transthoracic echocardiography, myocardial scintigraphy, and cardiac magnetic resonance, while coronary angiography revealed normal coronary arteries. Laboratory investigations excluded acquired or inherited thrombophilia, immunologic disorders, cardiotropic agents infection, and drug abuse. Antiplatelet therapy was started but, after 15 days, he was rehospitalized with diagnosis of multiple left renal infarctions. A transesophageal echocardiography (TEE) was so performed which excluded a right-to-left shunt, suggestive of patent foramen ovale, or other cardioembolic sources in heart chambers and valve apparatus. Antiplatelet therapy was replaced with oral anticoagulants without any further embolic event at one-year follow-up. This case raises two important questions regarding young patients with cryptogenic MI. First, if TEE should be part of a complete diagnostic pathway; second, if oral anticoagulants should be preferred over antiplatelets for secondary prevention particularly when the cause of MI remains unknown.

First Name
Last Name
Email Address
Comments
Security code


Abstract View:

Your browser does not support the canvas element.

PDF Download:

Your browser does not support the canvas element.


Full Text View:

Your browser does not support the canvas element.